...
首页> 外文期刊>Dermatologic surgery >Midterm results of radiofrequency ablation for incompetent small saphenous vein in terms of recanalization and sural neuritis
【24h】

Midterm results of radiofrequency ablation for incompetent small saphenous vein in terms of recanalization and sural neuritis

机译:在再通和腓肠神经炎方面,无功能小隐静脉射频消融的中期结果

获取原文
获取原文并翻译 | 示例

摘要

Background Safety and effectiveness of radiofrequency ablation for incompetent small saphenous vein is not established. Objective To report midterm clinical and ultrasonograhic results of radiofrequency ablation (RFA) for small saphenous vein (SSV) in terms of recanalization and sural neuritis. Methods and materials We examined 39 patients (46 limbs) who had been examined using a duplex scan more than 1 year after RFA of SSV. Postoperative clinical results, risk factors for SSV recanalization, and sural neuritis were analyzed. Results CEAP score and CIVIQ2 score improved significantly in all patients (CEAP: 2.45 to 1.43 (p =.03); CIVIQ2: 25.34 to 13.21 (p =.01). SSV obliteration rate was 93.4% at 1 year and 89.1% at 2 years. Preoperative peak reflux velocity in the recanalization group (54.9 cm/s) was significantly higher (p <.01) than in the obliteration group (29.8 cm/s). Sural neuritis were detected in 12 limbs (26.1%), and median symptom duration was 3 months. The total length of RFA ablation was not different between the groups with and without postablation sural neuritis. Conclusion RFA is an effective and safe treatment modality for incompetent SSV. Peak reflux velocity can be a risk factor for recanalization. Length of RFA segment in SSV does not affect recanalization and postablation sural neuritis.
机译:背景技术尚不能确定无能力的大隐静脉的射频消融的安全性和有效性。目的报道小隐隐静脉(SSV)射频消融(RFA)在再通和腓肠神经炎方面的中期临床和超声检查结果。方法和材料我们对39例患者(46肢)进行了SSV的RFA治疗后1年以上进行了双重扫描检查。分析术后的临床结果,SSV再通的危险因素和腓肠神经炎。结果所有患者的CEAP评分和CIVIQ2评分均显着改善(CEAP:2.45至1.43(p = .03); CIVIQ2:25.34至13.21(p = .01)。SSV清除率在1年时为93.4%,在2年时为89.1%。再通组的术前峰值反流速度(54.9 cm / s)明显高于闭塞组(29.8 cm / s)(p <.01),在12条肢体中发现了神经炎(26.1%),中位症状持续时间为3个月,RFA消融的总时长在有无消融后腓肠神经炎组之间无差异;结论RFA是治疗SSV不合格的有效且安全的方法,峰值返流速度可能是再次通气的危险因素。 SSV中RFA段的长度不影响再通和消融后腓肠神经炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号